WA
TAK icon

WPG Advisers’s Takeda Pharmaceutical TAK Stock Holding History

WPG Advisers’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01K Hold
63
– – ﹤0.01% 1328
2026
Q1 		$1.17K Hold
63
– – ﹤0.01% 1229
2025
Q4 		$982 Hold
63
– – ﹤0.01% 1294
2025
Q3 		$922 Hold
63
– – ﹤0.01% 1296
2025
Q2 		$974 Hold
63
– – ﹤0.01% 1275
2025
Q1 		$937 Sell
63
-362
-85% -$5.07K ﹤0.01% 1265
2024
Q4 		$5.63K Buy
+425
New +$5.84K 0.01% 791

Other funds holding TAK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

WPG Advisers's TAK Position: Q2 2026 in Review

WPG Advisers held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 63 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

WPG Advisers first reported a position in TAK in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.63K in Q4 2024. 201 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • WPG Advisers held 63 shares of Takeda Pharmaceutical worth $1.01K as of Q2 2026.
  • WPG Advisers left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1328 holding.
  • WPG Advisers first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Takeda Pharmaceutical position peaked at $5.63K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.